Advanced searchCitation search
Skip main navigation
Close Drawer MenuOpen Drawer Menu
Medicine and Public Issues1 October 1992

Effects of Offering Advance Directives on Medical Treatments and Costs

    Author, Article, and Disclosure Information
    https://doi.org/10.7326/0003-4819-117-7-599

    Abstract

    ▪ Objective: To examine the effects of advance directives on medical treatments and on patient satisfaction and well-being and to determine whether the enhancement of patient autonomy through advance directives provides a more ethically feasible approach to cost control than does the imposition of limits through rationing.

    ▪ Design: Randomized, controlled trial.

    ▪ Setting: University and Veterans Affairs medical center.

    ▪ Patients: Two hundred and four patients with life-threatening illnesses, 100 of whom died after enrollment in the study.

    ▪ Intervention: Patients randomly assigned to the experimental group were offered the California Durable Power of Attorney (a typical proxy-instruction directive), and patients assigned to the control group were not offered the advance directive. Hospital admissions were monitored to assure that a summary of the document was present in the active medical record at each hospitalization.

    ▪ Measurements: Cognitive function, patient satisfaction, pyschological well-being, health locus of control, sense of coherence, health-related quality of life, receipt of medical treatments, and medical treatment charges.

    ▪ Results: No significant differences were found between advance-directive and control groups regarding psychosocial variables, health outcome variables, and medical treatments or charges. Patients offered an advance directive had an average hospital stay of 40.8 days (95% CI, 32.2 to 49.4 days), compared with an average of 33.1 days (95% CI, 26.0 to 40.2 days) for controls. Patients offered an advance directive were charged an average of $19 502 (95% CI, $13 030 to $25 974) for medical treatments in the last month of life compared with $19 700 (95% CI, $13 704 to $25 696) for controls.

    ▪ Conclusions: Despite claims that public demand for longer life accounts for rising medical costs, most surveys suggest that patients are calling for less, not more, of the expensive, high-technology treatment often used in terminal phases of illness. Executing the California Durable Power of Attorney for Health Care and having a summary copy placed in the patient's medical record had no significant positive or negative effect on a patient's well-being, health status, medical treatments, or medical treatment charges.

    References

    • 1. Schneiderman L and Arras J. Counseling patients to counsel physicians on future care in the event of patient incompetence. Ann Intern Med. 1985;102:693-8. LinkGoogle Scholar
    • 2. Omnibus Reconciliation Act 1990. Title IV. Section 4206. Congressional Record, October 26, 1990:12638. Google Scholar
    • 3. Callahan D. What Kind of Life: The Limits of Medical Progress, New York: Simon and Schuster; 1990:80. Google Scholar
    • 4. Taylor H. Withholding and withdrawal of life support from the critically ill. N Engl J Med. 1990;322:1891-2. CrossrefMedlineGoogle Scholar
    • 5. Schneiderman L, Pearlman R, Kaplan R, Anderson J, and Rosenberg E. Relationship of general advance directive instructions to specific life-sustaining treatment preferences in patients with serious illness. Arch Intern Med. [In press.] Google Scholar
    • 6. Shmerling R, Bedell S, Lilienfeld A, and Delbanco T. Discussing cardiopulmonary resuscitation: a study of elderly outpatients. J Gen Intern Med. 1988;3:317-21. CrossrefMedlineGoogle Scholar
    • 7. Everhart M and Pearlman R. Stability of patient preferences regarding life-sustaining treatments. Chest. 1990;97:159-64. CrossrefMedlineGoogle Scholar
    • 8. Danis M, Southerland L, Garrett J, Smith J, Hielema F, and Pickard C. A prospective study of advance directives for life-sustaining care. N Engl J Med. 1991;324:882-8. CrossrefMedlineGoogle Scholar
    • 9. Emanuel L, Barry M, Stoeckle J, Ettelson L, and Emanuel E. Advance directives for medical care—a case for greater use. N Engl J Med. 1991;324:889-95. CrossrefMedlineGoogle Scholar
    • 10. Danis M, Patrick D, Southerland L, and Green M. Patients' and families' preferences for medical intensive care. JAMA. 1988;260:797-802. CrossrefMedlineGoogle Scholar
    • 11. Buchanan A and Brock D. Deciding for Others: The Ethics of Surrogate Decision Making. Cambridge: Cambridge University Press; 1989. Google Scholar
    • 12. Current Opinions of the Council on Ethical and Judicial Affairs of the American Medical Association. Chicago: American Medical Association; 1989:2.20, 2.21. Google Scholar
    • 13. Orentlicher D. Advance medical directives. JAMA. 1990;263:2365-7. CrossrefMedlineGoogle Scholar
    • 14. American Academy of Neurology. Resolution on legislation regarding durable power of attorney for health care. Minneapolis: American Academy of Neurology; 1989. Google Scholar
    • 15. The Hastings Center. Guidelines on the termination of life-sustaining treatment and the care of the dying. Bloomington: Indiana University Press; 1987. Google Scholar
    • 16. California Code. 1987 Supplement. 1985. Article 5, Sections 2430-2444. Google Scholar
    • 17. Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979;300:1242-5. CrossrefMedlineGoogle Scholar
    • 18. Folstein M, Folstein S, and McHugh P. Mini-Mental State: a practical method from grading the cognitive state of patients for the clinician. J Psych Res. 1979;12:189-98. CrossrefGoogle Scholar
    • 19. DiMatteo M and Hays R. The significance of patients' physician contact: a study of patient satisfaction in a family practice center. J Community Health. 1980;6:18-34. CrossrefMedlineGoogle Scholar
    • 20. Wan T and Liveratos B. Validating a general well-being index by clinical measures of health. Gerontologist. 1977;17:129-30. Google Scholar
    • 21. Fazio A. A concurrent validational study of the NCHS General Weil-Being Schedule. Vital Health Statistics, Series 2, 1977. Google Scholar
    • 22. Wallston K, Wallston B, and DeVellis R. Development of the multidimensional health locus of control scales. Health Education Monographs. 1976;16:160-70. Google Scholar
    • 23. Antonovsky A. Health, Stress and Coping: New Perspectives on Mental and Physical Well-Being. San Francisco: Jossey-Bass; 1981. Google Scholar
    • 24. Kaplan R and Anderson J. The general health policy modes: an integrated approach. In: Spilker B, ed. Quality of Life Assessments in Clinical Trials. New York: Raven, 1990:131-49. Google Scholar
    • 25. Kaplan R and Anderson J. A general health policy model: update and applications. Health Serv Res. 1988;23:203-35. MedlineGoogle Scholar
    • 26. Kaplan R, Bush J, and Berry C. Health status: types of validity for an index of well-being. Health Serv Res. 1976;11:478-507. MedlineGoogle Scholar
    • 27. Anderson J, Bush J, and Berry C. Classifying function for health outcome and QOL evaluation: self versus interviewer modes. Med Care. 1986;24:454-69. CrossrefMedlineGoogle Scholar
    • 28. Kaplan R, Anderson J, Wu A, Mathews W, Kozin F, and Orenstein D. The quality of well-being scale: applications in AIDS, cystic fibrosis, and arthritis. Med Care. 1989;27(Suppl 3):S27-S43. CrossrefMedlineGoogle Scholar
    • 29. Kaplan R. Quality of Life Assessment. In: Karoly P, ed. Measurement Strategies in Health Psychology. New York: Wiley; 1985:115-46. Google Scholar
    • 30. Langer R, Wark R, Schneiderman L, Kaplan R, Anderson J, and Chen M. A research-oriented medical cost accounting system. Int J Biomed Comput. 1991;28:161-7. CrossrefMedlineGoogle Scholar
    • 31. Scitovsky A. The high cost of dying: what do the data show? Milbank Memorial Fund Quarterly/Health and Society. 1984;62:591609. Google Scholar
    • 32. Lubitz J and Prihoda R. The use and costs of Medicare services in the last two years of life. Health Care Financ Rev. 1984;5:117-31. MedlineGoogle Scholar
    • 33. Bedell S and Delbanco K. Choices about cardiopulmonary resuscitation in the hospital: when do physicians talk with patients? N Engl J Med. 1984;310:1089-93. CrossrefMedlineGoogle Scholar
    • 34. Uhlmann R, Pearlman R, and Cain K. Understanding of elderly patients' resuscitation preferences by physicians and nurses. West J Med. 1989;150:705-7. MedlineGoogle Scholar
    • 35. Uhlmann R, Pearlman R, and Cain K. Physicians' and spouses' predictions of elderly patients' resuscitation preferences. J Gerontol. 1988;43:M115-21. CrossrefGoogle Scholar
    • 36. Seckler A, Meier D, Mulvihill M, and Paris B. Substituted judgment: how accurate are proxy predictions? Ann Intern Med. 1991;115:92-8. LinkGoogle Scholar
    • 37. Emanuel L and Emanuel E. The medical directive: a new comprehensive advance care document. JAMA. 1989;261:3288-93. CrossrefMedlineGoogle Scholar
    • 38. Brett A. Limitations of listing specific medical interventions in advance directives. JAMA. 1991;266:825-8. CrossrefMedlineGoogle Scholar

    This content is PDF only. To continue reading please click on the PDF icon.

    Previous
    Next

    Submit a Comment

    Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
    *All comments submitted after October 1, 2021 and selected for publication will be published online only.
    Cancel